Bayer Seeking Levitra Label Without Alpha Blocker Contraindication
This article was originally published in The Pink Sheet Daily
Executive Summary
Second quarter sales for Levitra were lower than expected, hampered by a slow erectile dysfunction market, the company says. Bayer remains optimistic about long-term Levitra sales growth despite competition from Pfizer and Lilly.